RDY

Q: What is the price of Dr. Reddy's Laboratories (RDY) today?

The current price of Dr. Reddy's Laboratories (RDY) is $ 13.30, representing a -2.27% gain over the past year. The stock began the year trading around $ 14.04 and is currently priced at $ 13.30. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Dr. Reddy's Laboratories (RDY) pay dividends?

Dr. Reddy's Laboratories (RDY) did not pay dividends over the past year.

Dr. Reddy's Laboratories Ltd.

Price

$ 13.30

return (12m)

-2.27%

p/e

17.06

p/bv

2.64

DIVIDEND YIELD

0.54%

RDY price

RDY

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment RDY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-4.15%

3 months

2.90%

1 year

-2.27%

2 years

-5.24%

5 years

3.78%

10 years

52.43%

Fundamentals RDY

review the fundamentals of Dr. Reddy's Laboratories shares

P/E

17.06

Sector: -2.14 Industry: 10.87

P/S (PSR)

2.80

Sector: 1.94 Industry: 1.57

P/BV

2.64

Sector: 2.13 Industry: 3.07

DIVIDEND YIELD (DY)

0.54%

Sector: - Industry: 0.01%

ROA

10.34%

Sector: -25.39% Industry: 2.70%

ROE

15.49%

Sector: -29.75% Industry: 5.25%

ROIC

11.21%

Sector: -418.64% Industry: -2.27%

NET MARGIN

16.39%

Sector: -27.73% Industry: 2.71%

GROSS MARGIN

57.93%

Sector: 44.91% Industry: 28.76%

OPERATING MARGIN

18.88%

Sector: -22.84% Industry: 1.39%

EV/EBITDA

10.08

Sector: -0.35 Industry: 3.98

EV/EBIT

12.67

Sector: -1.68 Industry: 2.39

PRICE-TO-ASSETS

1.76

Sector: 1.14 Industry: 1.42

BVPS

5.01

Sector: 3.83 Industry: 11.41

EPS

0.78

Sector: -0.89 Industry: 1.09

EQUITY-TO-ASSETS RATIO

0.67

Sector: 0.44 Industry: 0.46

LIABILITIES / ASSETS

0.33

Sector: 0.46 Industry: 0.52

CAGR REVENUE 5 YEARS

7.05%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

12.68%

Sector: - Industry: -

FAIR VALUE OF Dr. Reddy's Laboratories ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 13.30

Fair Value

$ 0.00

Upside/Downside Return potential.

-29.47%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals RDY

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	41.59	35.99	86.53%	0.65%	$ 858.38 B	31.66%
ISRG	56.96	9.07	15.92%	0.00%	$ 162.68 B	28.38%
TMO	27.82	3.48	12.52%	0.35%	$ 186.54 B	15.05%
SNY	12.68	1.38	10.86%	4.67%	$ 115.62 B	18.68%
NVS	21.29	6.40	30.04%	4.48%	$ 297.73 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.58	2.30	9.38%	2.41%	$ 113.37 B	13.00%
GSK	15.39	5.50	35.71%	3.00%	$ 117.42 B	17.48%
CVS	56.86	1.33	2.35%	3.36%	$ 100.53 B	0.44%
BSX	31.39	0.00	0.00%	0.00%	$ 90.98 B	14.44%
TMDX	19.73	7.94	40.22%	0.00%	$ 3.75 B	31.43%
HCA	17.15	-41.99	-244.82%	0.58%	$ 116.34 B	8.97%
IDXX	44.22	29.19	65.99%	0.00%	$ 46.85 B	24.62%
RMD	22.49	5.29	23.51%	1.02%	$ 33.42 B	27.53%
DHR	38.03	2.62	6.88%	0.66%	$ 137.43 B	14.71%
INMD	9.25	1.27	13.73%	0.00%	$ 868.14 M	25.32%
PHG	25.94	2.09	8.06%	3.13%	$ 26.91 B	5.07%
FMS	11.96	0.81	6.75%	3.34%	$ 13.50 B	5.02%
SYK	40.02	5.79	14.48%	1.00%	$ 129.89 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

RDY Historical Dividends

current DY: 0.54%

5-year average DY: 0.63%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	07/10/2025	08/06/2025	0,07150000
Dividends	07/15/2024	08/12/2024	0,09524000
Dividends	07/10/2023	08/11/2023	0,09652000
Dividends	07/11/2022	08/12/2022	0,07568000
Dividends	07/09/2021	08/11/2021	0,06840000
Dividends	07/13/2020	08/17/2020	0,06668000
Dividends	07/15/2019	08/15/2019	0,05644000
Dividends	07/16/2018	08/09/2018	0,05840000
Dividends	07/17/2017	08/10/2017	0,06278000
Dividends	07/18/2016	08/09/2016	0,05990000
Dividends	07/10/2015	08/17/2015	0,06258000
Dividends	07/11/2014	08/15/2014	0,06060000
Dividends	07/12/2013	08/15/2013	0,05280000
Dividends	06/29/2012	08/06/2012	0,04580000
Dividends	07/01/2011	08/11/2011	0,05092000
Dividends	06/16/2011	06/23/2011	0,13206000
Dividends	07/02/2010	08/17/2010	0,04826000
Dividends	07/07/2009	08/12/2009	0,02608000
Dividends	07/08/2008	08/18/2008	0,01776000
Dividends	07/10/2007	08/10/2007	0,01858000
Dividends	07/11/2006	08/21/2006	0,01072000
Dividends	07/11/2005	08/16/2005	0,01148000
Dividends	07/19/2004	08/24/2004	0,01076000
Dividends	08/11/2003	10/02/2003	0,01092000
Dividends	08/12/2002	09/30/2002	0,00510000
Dividends	11/23/2001	12/13/2001	0,01042000

ABOUT Dr. Reddy's Laboratories

Dr. Reddy's Laboratories Ltd.

Average Investor10 user rating

4.0 (3 people)

United States

42 years

Founded: 1984

2001

Time since IPO - 25 years

22.740

Employees

Dr. Reddy's Laboratories Ltd. (United States) is listed on the NYSE and has a market capitalization of $11.03 Billions, with shareholders equity totaling $4.17 Billions.

The company employs approximately 22.740 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Dr. Reddy's Laboratories Ltd. reported $3.94 Billions in revenue, generating net income of $646.34 Millions.

Key financial metrics include a P/E ratio of 17.06, a price-to-book (P/B) ratio of 2.64, and a trailing twelve-month dividend yield of 0.54%.

The company trades under the ticker RDY.

Market cap

$ 11.03 Billions

Net worth

$ 4.17 Billions

$ 4,173,440,000.00

Assets

$ 6.25 Billions

$ 6,252,000,000.00

Total Shares Outstanding

833.00 Millions

833,000,000

Average Daily Trading Volume

$ 2.19 Millions

$ 2,192,284.42

Sector

Health

Industry

Pharmaceutical Products

RDY

RDY revenue and profits

Financial Results RDY

DRAG THE FRAME TO SEE MORE DATA

RDY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 77.30 20,27% (12M)

P/E

56.86

3.36%

ROE

2.35%

P/BV

1.33

CI - Cigna

$ 278.64 --13,81% (12M)

P/E

10.78

2.19%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 38.17 --37,12% (12M)

P/E

-2.75

0.00%

ROE

-33.28%

P/BV

0.91

HUM - Humana

$ 205.14 --20,95% (12M)

P/E

19.94

1.79%

ROE

6.70%

P/BV

1.34

HCA - HCA Healthcare

$ 488.00 46,66% (12M)

P/E

17.15

0.58%

ROE

-244.82%

P/BV

-41.99

LLY - Eli Lilly

$ 927.03 14,15% (12M)

P/E

41.59

0.65%

ROE

86.53%

P/BV

35.99

NVS - Novartis

$ 151.97 44,80% (12M)

P/E

21.29

4.48%

ROE

30.04%

P/BV

6.40